CHICAGO, IL / ACCESS Newswire / July 9, 2025 / Dr. Anosh Ahmed, a respected Republican figure and founder of the Anosh Supports America First Foundation, has pledged immediate aid to families affected ...

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in ...

Design Sets a New 2025 Bar for Healthcare AI TAMPA, FL / ACCESS Newswire / July 8, 2025 / While healthcare AI adoption is frequently hindered by poor design, weak integration, and limited clinician ...

While more than 90% of Americans support organ donation, only 52% of North Carolina's licensed drivers are registered organ, ...

Gut Zoomer provides insights crucial in identifying the root causes of chronic disease and other conditions that impact longevity SANTA CLARA, CA / ACCESS Newswire / July 8, 2025 / Vibrant Wellness, a ...

Modus Therapeutics Holding AB (publ) (“Modus”) today announces that patient enrollment in Part 1 of its ongoing Phase IIa study evaluating sevuparin for the treatment of patients with chronic kidney ...

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Hone Health At-Home Testosterone Test + Telemedicine TRTHone Health is on a mission to provide the best TRT services. It just announced it's taking its ...

First-in-human administration of CPV-104 marks a major step in drug development for the company’s lead compound (Factor H) and in bringing a new medication to patientsFreiburg im Breisgau, Germany, ...

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Eladynos® for the treatment of osteoporosis in postmenopausal women at very high risk of fracture*, through the NHS ...

Led Network Rooted in Clinical Excellence and Shared Values CHICAGO, IL / ACCESS Newswire / July 8, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists ...

Expanded offering delivers integrated radiopharmaceutical studies using clinically relevant isotopes and highly characterized PDX tumor models HACKENSACK, NJ / ACCESS Newswire / July 8, 2025 / ...

This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial ...